Proteostasis Therapeutics Inc (NASDAQ:PTI)

2.73
Delayed Data
As of Jul 20
 -0.05 / -1.80%
Today’s Change
1.41
Today|||52-Week Range
8.61
-53.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues5.2M4.3M8.4M5.3M
 
 
 
 
 
Depreciation And Amortization427.0K272.0K306.0K235.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.4M28.6M45.5M65.1M
 
 
 
 
 
Research And Development16.7M22.5M34.0M53.7M
 
 
 
 
 
Total Operating Expenses20.8M28.8M45.8M65.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.7M-24.5M-37.5M-60.0M
 
 
 
 
 
Extraordinary Credit--0.000.0066.0K
 
 
Extraordinary Charge-76.0K-63.0K-7.0K0.00
 
 
 
 
Interest Expense On Debt199.0K599.0K0.000.00
 
 
 
Other Expenses185.0K156.0K-16.0K-166.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.8M-25.0M-37.2M-59.4M
 
 
 
 
 
Preferred Dividend-13.9M-1.7M-1.4M0.00
 
 
 
 
Net Income-15.8M-25.0M-37.2M-59.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.9M24.9M18.8M25.4M
 
 
 
 
 
Shares To Calculate EPS Diluted24.9M24.9M18.8M25.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.19-$0.94-$2.06-$2.34
 
 
 
 
 
EPS Diluted-$1.19-$0.94-$2.06-$2.34